Kiora Pharmaceuticals Inc

XNAS:KPRX 4:00:00 PM EDT

2.49

-0.02 (-0.80%)

5:32:40 PM EDT: $2.53 +0.04 (+1.61%)

Kiora Pharmaceuticals Inc Stock, XNAS:KPRX

332 Encinitas Boulevard, Suite 102, Encinitas, California 92024

United States of America

Phone: +1.858.224.9600

Number of Employees: 12

http://www.kiorapharma.com

Description

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.